My questions are:
1. When the hell are you going to work on stopping the neuronal cascade of death?
2. When will you pick an objective diagnosis tool? so that people don't wait in emergency rooms until their symptoms are obvious.
3. When will you publically publish stroke protocols for ERs, rehab departments so patients can make informed decisions about where to go and where to avoid?
Dr. Sacco, as president of the ASA you are in position to drive these answers if you have any competency to meet survivor needs. Its been 2 months since this ended, you should have focus groups working on solving these problems and a first report soon.
http://www.medpagetoday.com/Cardiology/Strokes/37322?
The International Stroke Conference has wrapped up in Honolulu, but
the results of many of the clinical trials presented will be
reverberating for a long time to come, says Ralph L. Sacco, MD, in this
exclusive InFocus interview.
Just about all of the trials that tested an endovascular therapeutic
approach to ischemic stroke could not show the intra-arterial technique
was better than standard intravenous thrombolysis with tissue
plasminogen activator (tPA).
But these trials were not done in vain, said Sacco, a former
president of the American Heart Association and chair of neurology at
the University of Miami Miller School of Medicine. They raise important
questions that need to be answered going forward, and they pave the way
for testing newer devices and drugs.
A few trials testing secondary stroke prevention had conflicting findings, but Sacco explained to MedPage Today cardiology editor Chris Kaiser how they might be interpreted.
And finally, there was some promising news regarding the treatment of
intracerebral hemorrhagic stroke, which, Sacco said, is particularly
welcome for this devastating and challenging type of stroke.
No comments:
Post a Comment